CD44 and head and neck squamous cell carcinoma: In one study analyzing CSC markers as prognostic factors for HNSCC, it was observed that both Bmi-1 and CD44 are indicators for poorer prognosis of overall and disease-free survival in patients receiving primary radio-chemotherapy irrespective of HPV status (n = 85) (112).